← Leaderboards
Anthony W Maresso
University Of Chicago
$18,790,258
Attributed
$21,409,939
Total exposure
21
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $18.1M · FY2007–25$20M$15M$10M$5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$51,851,384 · 24
By mechanism
U19$39,350,699 · 8
R01$7,260,657 · 3
R21$4,012,736 · 9
R56$899,210 · 2
K22$270,000 · 1
F32$58,082 · 1
Top collaborators
- Mary Kolb Estes8 shared
- Pedro A Piedra7 shared
- Robert A Britton6 shared
- Katherine Paige Lemon6 shared
- Vanessa Sperandio6 shared
- Katy Patras5 shared
- Saima Aslam2 shared
- Shelley M. Payne2 shared
Most similar at University Of Chicago
Same institution · by research overlap
- John Keith Moffat$30,577,550
- Philip A Verhoef$813,776
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionPathogenBacteriaSurfaceCellsComplexPreventPathogenesisTissuesVaccinesMolecularBiological ModelsGastrointestinal Tract StructureAntibioticsPropertyResponseGrowthMediatingIntestinesGenesMedicineCommunitiesEnvironmentMucous Membrane
Grant awards (70)
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces$2,479,201
U19 · FY2025 · AI
Human Biomimetics for Mucosal Infections$1,617,959
U19 · FY2025 · AI
Mechanistic insights into bacteriophage properties required for enhanced therapeutic potential at mucosal surfaces$526,927
U19 · FY2025 · AI · contact PI
Human Gastrointestinal Biomimetics for Enteric Bacterial Infections$408,371
U19 · FY2025 · AI · contact PI
Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients$317,863
R01 · FY2025 · DK
Phage-Bacteria Evolution via Next-Generation Phage Bioreactors$234,375
R21 · FY2025 · AI · contact PI
Integrated Genomics of Mucosal Infections$9,954,734
U19 · FY2024 · AI
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces$2,497,111
U19 · FY2024 · AI
Human Biomimetics for Mucosal Infections$1,557,840
U19 · FY2024 · AI
Functional Genomics of Pathogenic Enterobacteriaceae$1,434,869
U19 · FY2024 · AI · contact PI
Sugar regulation of EHEC virulance$611,785
R01 · FY2024 · AI
Mechanistic insights into bacteriophage properties required for enhanced therapeutic potential at mucosal surfaces$560,449
U19 · FY2024 · AI · contact PI
ExPEC Vaccine Development$400,000
R56 · FY2024 · AI · contact PI
Human Gastrointestinal Biomimetics for Enteric Bacterial Infections$359,541
U19 · FY2024 · AI · contact PI
Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients$332,372
R01 · FY2024 · DK
Phage-Bacteria Evolution via Next-Generation Phage Bioreactors$281,250
R21 · FY2024 · AI · contact PI
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces$119,807
U19 · FY2024 · AI
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces$2,537,842
U19 · FY2023 · AI
Human Biomimetics for Mucosal Infections$1,557,840
U19 · FY2023 · AI
Sugar regulation of EHEC virulance$611,785
R01 · FY2023 · AI
The Genomics and Antagonism of Pathobiont Colonization$557,142
U19 · FY2023 · AI · contact PI
Human Gastrointestinal Biomimetics for Enteric Bacterial Infections$554,168
U19 · FY2023 · AI · contact PI
Mechanistic insights into bacteriophage properties required for enhanced therapeutic potential at mucosal surfaces$542,612
U19 · FY2023 · AI · contact PI
Human Biomimetics for Mucosal Infections$73,545
U19 · FY2023 · AI
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces$2,402,665
U19 · FY2022 · AI
Human Biomimetics for Mucosal Infections$1,557,840
U19 · FY2022 · AI
Sugar regulation of EHEC virulance$611,785
R01 · FY2022 · AI
The Genomics and Antagonism of Pathobiont Colonization$557,143
U19 · FY2022 · AI · contact PI
Mechanistic insights into bacteriophage properties required for enhanced therapeutic potential at mucosal surfaces$400,444
U19 · FY2022 · AI · contact PI
Nutrient Uptake during Anthrax Disease$396,250
R01 · FY2022 · AI · contact PI
Human Gastrointestinal Biomimetics for Enteric Bacterial Infections$347,246
U19 · FY2022 · AI · contact PI
Human Biomimetics for Mucosal Infections$76,678
U19 · FY2022 · AI
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces$2,390,117
U19 · FY2021 · AI
Human Biomimetics for Mucosal Infections$1,618,266
U19 · FY2021 · AI
The Genomics and Antagonism of Pathobiont Colonization$736,728
U19 · FY2021 · AI · contact PI
Sugar regulation of EHEC virulence$638,835
R01 · FY2021 · AI
Mechanistic insights into bacteriophage properties required for enhanced therapeutic potential at mucosal surfaces$545,053
U19 · FY2021 · AI · contact PI
Human Gastrointestinal Biomimetics for Enteric Bacterial Infections$427,286
U19 · FY2021 · AI · contact PI
Nutrient Uptake during Anthrax Disease$396,250
R01 · FY2021 · AI · contact PI
Sugar regulation of EHEC virulence$653,082
R01 · FY2020 · AI
The Genomics and Antagonism of Pathobiont Colonization$456,871
U19 · FY2020 · AI · contact PI
Nutrient Uptake during Anthrax Disease$396,250
R01 · FY2020 · AI · contact PI
Branched Chain Amino Acid Metabolism During Anthrax$200,000
R21 · FY2020 · AI · contact PI
The Genomics and Antagonism of Pathobiont Colonization$494,404
U19 · FY2019 · AI · contact PI
Nutrient Uptake during Anthrax Disease$396,250
R01 · FY2019 · AI · contact PI
Branched Chain Amino Acid Metabolism During Anthrax$239,813
R21 · FY2019 · AI · contact PI
Sugar Regulation of EHEC virulence - A1$499,210
R56 · FY2018 · AI
Nutrient Uptake during Anthrax Disease$356,625
R01 · FY2018 · AI · contact PI
Next-stage Development of Heme Transporters as a Vaccine for Anthrax$237,750
R21 · FY2018 · AI · contact PI
The Importance and Function of Heme Degrading Enzymes during Anthrax Disease$198,125
R21 · FY2018 · AI · contact PI
A colonoid model for Shigella flexneri pathogenesis$196,885
R21 · FY2018 · AI
A colonoid model for Shigella flexneri pathogenesis$250,135
R21 · FY2017 · AI
The Importance and Function of Heme Degrading Enzymes during Anthrax Disease$237,750
R21 · FY2017 · AI · contact PI
Next-stage Development of Heme Transporters as a Vaccine for Anthrax$198,125
R21 · FY2017 · AI · contact PI
The Role of FimH in ExPEC Translocation$198,125
R21 · FY2017 · AI · contact PI
The Role of FimH in ExPEC Translocation$237,750
R21 · FY2016 · AI · contact PI
Targeting Heme Transporters for Improved Vaccines against Anthrax$198,125
R21 · FY2016 · AI · contact PI
Iron Acquisition in Anthrax$391,250
R01 · FY2015 · AI · contact PI
Targeting Heme Transporters for Improved Vaccines against Anthrax$236,876
R21 · FY2015 · AI · contact PI
Iron Acquisition in Anthrax$391,250
R01 · FY2014 · AI · contact PI
Iron Acquisition in Anthrax$367,775
R01 · FY2013 · AI · contact PI
Bacterial Heme Transport by non-Isd NEAT Proteins$195,625
R21 · FY2013 · AI · contact PI
Iron Acquisition in Anthrax$391,250
R01 · FY2012 · AI · contact PI
Bacterial Heme Transport by non-Isd NEAT Proteins$234,750
R21 · FY2012 · AI · contact PI
Optical Imaging to Monitor Heme Acquisition during Bacterial Infection$229,484
R21 · FY2012 · AI · contact PI
Optical Imaging to Monitor Heme Acquisition during Bacterial Infection$207,793
R21 · FY2011 · AI · contact PI
Characterization of Heme Acquisition in Bacillus Anthracis$108,000
K22 · FY2010 · AI · contact PI
Characterization of Heme Acquisition in Bacillus Anthracis$162,000
K22 · FY2009 · AI · contact PI
Characterization of Heme Acquisition in B. anthracis$13,236
F32 · FY2008 · AI · contact PI
Characterization of Heme Acquisition in B. anthracis$44,846
F32 · FY2007 · AI · contact PI